Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry

被引:0
|
作者
Steinmetz, H. T. [1 ]
Boettger, I [1 ]
Lathan, B. [1 ]
Sauer, A. [1 ]
Severin, K. [1 ]
Germing, U. [1 ]
Schmitz, S. [1 ]
机构
[1] Uniklin Dusseldorf, Med Klin Hamatol & Onkol, Dusseldorf, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V722
引用
收藏
页码:234 / 234
页数:1
相关论文
共 50 条
  • [1] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) - update of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Sauer, A.
    Buschmann, D.
    Germing, U.
    Severin, K.
    Steinmetz, H. T.
    [J]. ONKOLOGIE, 2013, 36 : 242 - 242
  • [2] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) in outpatient clinics - results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Welslau, M.
    Lerchenmueller, C.
    Sauer, A.
    Germing, U.
    [J]. ONKOLOGIE, 2011, 34 : 289 - 289
  • [3] Diagnostic procedures and treatment of patients with myelodysplastic syndromes (MDS) in outpatient clinics. Results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I.
    Schnell, R.
    Sauer, A.
    Linde, H.
    Severin, K.
    Germing, U.
    Steinmetz, T.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S115 - S115
  • [4] Update on myelodysplastic syndromes (MDS)
    Hector Rodriguez, Jose
    del Lujan Acosta, Irma
    [J]. REVISTA MEDICA DE ROSARIO, 2011, 77 (01): : 24 - 41
  • [5] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) of low and intermediate-1 risk. Results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Schnell, R.
    Lerchenmueller, C.
    Sauer, A.
    Severin, K.
    Germing, U.
    Steinmetz, H. T.
    [J]. ONKOLOGIE, 2012, 35 : 148 - 148
  • [6] Mutations of myelodysplastic syndromes (MDS): An update
    Ganguly, Bani Bandana
    Kadam, N. N.
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2016, 769 : 47 - 62
  • [7] Treatment Outcome of Patients with Myelodysplastic Syndromes (MDS) in Regular Care: Incidence of IPSS Risk Groups and Different Therapies in the German Outpatient MDS Registry
    Steinmetz, H. Tilman
    Boettger, Isolde
    Lathan, Bernd
    Sauer, Annette
    Moorahrend, Enno
    Severin, Kai
    Germing, Ulrich
    Schmitz, Stephan
    Gattermann, Norbert
    [J]. BLOOD, 2014, 124 (21)
  • [8] The need for transfusions in patients with lower risk myelodysplastic syndrome (MDS). Data from the regular care MDS-registry in Germany
    Steinmetz, T.
    Toczek-Thiel, J.
    Hellmich, M.
    Aludin, R.
    Lipke, J.
    Liersch, R.
    Sauer, A.
    Tesch, H.
    Hessling, J.
    Schmitz, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 95 - 95
  • [9] CLASSIFICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS)
    CATOVSKY, D
    [J]. MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 : 3 - 3
  • [10] Cyclosporin A in the treatment of myelodysplastic syndromes (MDS)
    Shirin, AD
    Volkova, MA
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 416 - 416